What is the global market size of the Transplantation?

Global Transplantation Market size was valued at USD 13.72 Billion in 2021 and is poised to grow from USD 15 Billion in 2022 to USD 30.54 Billion by 2030, at a CAGR of 9.3% during the forecast period (2023-2030).

Top Transplantation Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Transplantation Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Transplantation industry players.

Transplantation Market Competitive Landscape

Transplantation Market Top Player’s Company Profiles

Medtronic (US)

Novartis AG (Switzerland)

AbbVie Inc. (US)

Zimmer Biomet Holdings, Inc. (US)

Stryker Corporation (US)

CSL Limited (Australia)

Johnson & Johnson (US)

Roche Holding AG (Switzerland)

Pfizer Inc. (US)

Sanofi (France)

Merck & Co., Inc. (US)

Astellas Pharma Inc. (Japan)

Bristol-Myers Squibb Company (US)

Takeda Pharmaceutical Company Limited (Japan)

AstraZeneca (UK)

GlaxoSmithKline plc (UK)

Fresenius Medical Care AG & Co. KGaA (Germany)

Integra LifeSciences Holdings Corporation (US)

Organogenesis Holdings Inc. (US)

Terumo Corporation (Japan)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Transplantation Market size was valued at USD 16.85 Billion in 2024 and is poised to grow from USD 18.35 Billion in 2025 to USD 36.3 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026–2033).

The global transplantation market is highly competitive in nature and consists of several major players striving to maintain their market positions. These companies are engaged in developing innovative products and expanding their geographic presence through strategic collaborations, mergers, and acquisitions. The competitive landscape is characterized by intense competition, technological advancements, and a focus on research and development to improve transplant outcomes. To gain a competitive edge, market players are investing significantly in research and development activities to develop innovative solutions and improve the success rates of transplantation procedures. They also focus on expanding their product portfolios through strategic acquisitions and collaborations with research institutions and other industry players. For instance, Medtronic, a leading player in the transplantation market, has been actively involved in developing advanced surgical tools, organ preservation solutions, and immunosuppressive therapies. 'AbbVie Inc. (USA) ', 'BioLife Solutions (USA) ', 'Medtronic (USA) ', 'Arthrex, Inc. (USA) ', 'Zimmer Biomet (USA) ', '21st Century Medicine (USA) ', 'Novartis AG (Switzerland) ', 'Stryker (USA) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'Veloxis Pharmaceuticals, Inc. (USA) ', 'TransMedics Inc. (USA) ', 'Hoffmann-La Roche Ltd. (Switzerland) ', 'Astellas Pharma Inc. (Japan) ', 'Preservation Solutions, Inc. (USA) ', 'OrganOx Limited (UK) ', 'Terumo Corporation (Japan) ', 'Transonic (USA) ', 'Sanofi (France) ', 'Pfizer Inc. (USA) ', 'CareDx, Inc. (USA) '

The rising incidence of chronic diseases such as end-stage renal disease, liver cirrhosis, heart failure, and respiratory disorders has fueled the demand for organ transplantation. For example, the growing number of patients with diabetes and its complications has led to a higher demand for kidney and pancreas transplants.

Growing Focus on Precision Medicine: Precision medicine approaches aim to personalize transplant therapies by considering individual genetic profiles, immunological compatibility, and disease characteristics. This trend includes the use of biomarkers, genetic testing, and advanced diagnostics to tailor immunosuppressive therapies and optimize patient outcomes.

In 2022, North America emerged as the dominant region in the transplantation market capturing a market share of 39.0%. This region is expected to maintain its dominance throughout the study period. The well-developed healthcare facilities and the presence of major biotechnology and medical devices companies, including Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, and Stryker, contribute to the market's growth in this region. However, there is a growing gap between the demand and supply of organs such as kidneys, livers, and hearts for transplantation. To address this issue, governments and non-governmental organizations (NGOs) in various countries have initiated programs to encourage organ donation and save lives. The implementation of new guidelines and rules for organ donation has made the process more transparent and accessible.

Top Transplantation Companies

Transplantation Market Competitive Landscape

FAQs

What is the global market size of Transplantation Market?

Who are the key vendors in the Transplantation Market?

What is the key driver of Transplantation Market?

What is the key market trend for Transplantation Market?

Which region accounted for the largest share in Transplantation Market?

Request Free Customization